Anti-Müllerian hormone serum concentrations of women with germlineBRCA1orBRCA2mutations

Anti-Müllerian Hormone and Lifestyle, Reproductive, and Environmental Factors Among Women in Rural South Africa

(2015) Kristina W. Whitworth et al.   EPIDEMIOLOGY

Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool

(2015) Richard A. Anderson et al.   FERTILITY AND STERILITY

What is the “ovarian reserve”?

(2015) John K. Findlay et al.   FERTILITY AND STERILITY

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

(2015) Felix R Day et al.   NATURE GENETICS

First fully automated immunoassay for anti-Müllerian hormone

(2014) Dieter Gassner et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Amh values in reproductive aged women with and without the brca1 mutation

(2014) M.E. Pavone et al.   FERTILITY AND STERILITY

BRCA1 germline mutations may be associated with reduced ovarian reserve

(2014) Erica T. Wang et al.   FERTILITY AND STERILITY

Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response

(2014) Stamatina Iliodromiti et al.   HUMAN REPRODUCTION UPDATE

BRCA Mutation Carriers Do Not Have Compromised Ovarian Reserve

(2014) Rachel Michaelson-Cohen et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Age-Related Decline in DNA Repair Function Explains Diminished Ovarian Reserve, Earlier Menopause, and Possible Oocyte Vulnerability to Chemotherapy in Women WithBRCAMutations

(2014) Kutluk Oktay et al.   JOURNAL OF CLINICAL ONCOLOGY

Reversal of Female Infertility by Chk2 Ablation Reveals the Oocyte DNA Damage Checkpoint Pathway

(2014) E. Bolcun-Filas et al.   SCIENCE

Comparison of age at natural menopause inBRCA1/2mutation carriers with a non-clinic-based sample of women in northern California

(2013) Wayne T. Lin et al.   CANCER

Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation

(2013) Amy Finch et al.   FERTILITY AND STERILITY

Reproductive and Lifestyle Determinants of Anti-Müllerian Hormone in a Large Population-based Study

(2013) M. Dólleman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data

(2013) Stamatina Iliodromiti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone

(2013) Fahimeh Ramezani Tehrani et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Do BRCA1 and BRCA2 Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer

(2013) Ian M. Collins et al.   JOURNAL OF CLINICAL ONCOLOGY

Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans

(2013) S. Titus et al.   Science Translational Medicine

Impact of breast cancer on anti-mullerian hormone levels in young women

(2012) H. I. Su et al.   BREAST CANCER RESEARCH AND TREATMENT

Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study

(2012) Casper P. Hagen et al.   FERTILITY AND STERILITY

Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways

(2012) Lisette Stolk et al.   NATURE GENETICS

Pretreatment Serum Anti-Müllerian Hormone Predicts Long-Term Ovarian Function and Bone Mass after Chemotherapy for Early Breast Cancer

(2011) Richard A. Anderson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women

(2011) S. L. Broer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Antimüllerian Hormone as a Predictor of Natural Fecundability in Women Aged 30–42 Years

(2011) Anne Z. Steiner et al.   OBSTETRICS AND GYNECOLOGY

A Validated Model of Serum Anti-Müllerian Hormone from Conception to Menopause

(2011) Thomas W. Kelsey et al.   PLoS One

Correlation of ovarian reserve tests with histologically determined primordial follicle number

(2010) Karl R. Hansen et al.   FERTILITY AND STERILITY

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks

(2009) Kutluk Oktay et al.   JOURNAL OF CLINICAL ONCOLOGY

The DNA-damage response in human biology and disease

(2009) Stephen P. Jackson et al.   NATURE

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

(2008) A C Antoniou et al.   BRITISH JOURNAL OF CANCER

Anti-Mullerian Hormone and Inhibin B in the Definition of Ovarian Aging and the Menopause Transition

(2008) MaryFran R. Sowers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM